The synthesis of novel Glp-1 receptor agonists presents a unique opportunity for pharmaceutical developers. Biopharmaceutical companies frequently require dedicated manufacturing processes to address the specific requirements of these complex molecules. Our group provides flexible GLP-1 receptor ago